Overview

Terlipressin Alone Versus the Standard Therapy With Catecholamines for Hepatic Patients With Septic Shock- Prospective Single Center Randomized Controlled Study.

Status:
Unknown status

Trial end date:
2020-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the use of terlipressin compared to standard regimen in hepatic patients with septic shock. Another aim is to compare the mortality rate & the effects on renal functions in both groups.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

National Hepatology & Tropical Medicine Research Institute

Treatments:

Epinephrine
Lypressin
Norepinephrine
Terlipressin